Fintechs that raked in profits from high interest rates now face a key test

Fintechs that raked in profits from high interest rates now face a key test


Key Points
  • In 2024, several fintechs — including Robinhood, Revolut and Monzo — saw a boost to their bottom lines from higher interest rates.
  • Now, they face a key test as a broad decline in interest rates raises doubts about the sustainability of relying on this heightened income over the long term.
  • Lindsey Naylor, partner at Bain & Company, said dropping benchmark rates could be “a test of the resilience of fintech firms’ business models.”



Source

Xpeng defies China’s EV price war with steady sales as Tesla and local rivals try to keep pace
Finance

Xpeng defies China’s EV price war with steady sales as Tesla and local rivals try to keep pace

Key Points Xpeng reported an eighth-straight month of more than 30,000 monthly vehicle deliveries amid a fierce price war in China. Xpeng’s U.S.-listed rivals, which target a more premium segment of China’s car market, saw more modest sales momentum. BYD remained the market giant, with its passenger car sales edging higher in June to 377,628 […]

Read More
Billionaire Ken Griffin’s hedge funds at Citadel are all in the green for 2025
Finance

Billionaire Ken Griffin’s hedge funds at Citadel are all in the green for 2025

Citadel CEO Ken Griffin speaks during the Semafor World Economy Summit 2025 at Conrad Washington on April 23, 2025 in Washington, DC. Kayla Bartkowski | Getty Images Billionaire investor Ken Griffin’s hedge funds at Citadel have all posted positive returns during a volatile 2025, led by the tactical trading fund. Citadel’s multistrategy Wellington fund, its largest, gained […]

Read More
Stocks making the biggest moves midday: Tesla, Tandem Diabetes, GE Vernova, Hasbro and more
Finance

Stocks making the biggest moves midday: Tesla, Tandem Diabetes, GE Vernova, Hasbro and more

Check out the companies making the biggest moves midday: Diabetes tech stocks — The Centers for Medicare & Medicaid Services is proposing a rule change that could change the reimbursement rates for continuous glucose monitors and insulin pumps. The news sent shares of diabetes tech stocks lower. Tandem Diabetes Care and Beta Bionics tumbled 4% […]

Read More